Tuesday, December 1, 2015

West Chester University taps into local pharma business knowledge

West Chester University's pharmaceutical product development program will feature lecturers from Exton-based ViroPharma, Inc., for an entire semester of seminars, starting Aug. 28.

West Chester University taps into local pharma business knowledge


The Philadelphia suburbs have numerous pharmaceutical businesses, big and small, and West Chester University is trying to tap into that knowledge for its academic programs - and jobs for students.

The school's 12-year-old pharmaceutical product development program will feature Exton-based ViroPharma, Inc., for an entire semester of seminars, starting Aug. 28.

The weekly series is called “Navigating Rare Disease: From Patient Needs to Solutions,” and is scheduled to have lectures by various ViroPharma staff members, including chief executive officer Vincent Milano. A scientist and a patient are also part of the lineup.

The PPD program accepts about a dozen students per year, some of whom are surely happy to know that the program involves paid internships, which can be rare in this economy. The school says graduates typically accept positions within the pharmaceutical and biotech industries within a month of graduating, or go to grad school or med school.

“This is graduate-level material being presented to our undergraduate students directly from ViroPharma company representatives," West Chester's Dr. Stephen J. Zimniski, director of the PPD program, said in a statement. "It represents the kind of deep involvement our students experience with our pharmaceutical and biotech partners in this unique program, as students are truly at the forefront of current medical developments.”

A link to the program on the school's website is here.

Inquirer Staff Writer
We encourage respectful comments but reserve the right to delete anything that doesn't contribute to an engaging dialogue.
Help us moderate this thread by flagging comments that violate our guidelines.

Comment policy:

Philly.com comments are intended to be civil, friendly conversations. Please treat other participants with respect and in a way that you would want to be treated. You are responsible for what you say. And please, stay on topic. If you see an objectionable post, please report it to us using the "Report Abuse" option.

Please note that comments are monitored by Philly.com staff. We reserve the right at all times to remove any information or materials that are unlawful, threatening, abusive, libelous, defamatory, obscene, vulgar, pornographic, profane, indecent or otherwise objectionable. Personal attacks, especially on other participants, are not permitted. We reserve the right to permanently block any user who violates these terms and conditions.

Additionally comments that are long, have multiple paragraph breaks, include code, or include hyperlinks may not be posted.

Read 0 comments
comments powered by Disqus
About this blog
David Sell blogs about the region's pharmaceutical industry. Follow him on Facebook.

Portions of this blog may also be found in the Inquirer's Sunday Health Section.

Reach David at dsell@phillynews.com or 215-854-4506.

David Sell Inquirer Staff Writer
Also on Philly.com:
letter icon Newsletter